Curcumin enhances bedaquiline’s efficacy against Mycobacterium abscessus : in vitro and in vivo evidence
Microbiology Spectrum · 2025
DOI: 10.1128/spectrum.02295-24 ↗Kurz gefasst
Fachartikel in der Zeitschrift Microbiology Spectrum, 2025. Verfasst von Dan Luo und 2 weiteren Autor:innen. Beteiligte Einrichtung: Shanghai Key Laboratory of Veterinary Biotechnology, School of Agriculture and Biology, Shanghai Jiao Tong University, Shanghai, Shanghai, China. Hauptthemen laut MEDLINE: Diarylquinolines, Mycobacterium abscessus, Mycobacterium Infections, Nontuberculous, Curcumin. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: MOST | National Key Research and Development Program of China (NKPs), MOST | National Natural Science Foundation of China (NSFC), SHANGHAI BIOMEDICAL SCIENCE AND TECHNOLOGY SUPPORT SPECIAL PROJECT.
Abstract (Originalsprache)
In this study, we describe the combined effects of bedaquiline (BDQ) and the natural product curcumin (CUR) on Mycobacterium abscessus . In both in vitro and in vivo experiments, CUR enhanced BDQ’s inhibitory effect. This combination reduced M. abscessus survival under nutrient-deprived, hypoxic, and acidic conditions, accelerated ATP depletion, mitigated BDQ-induced respiratory compensation, and effectively improved infection outcomes in both normal and immunosuppressed mice. Metabolomics analysis revealed that adding CUR to BDQ exacerbated BDQ-dependent downregulation of purine and pyrimidine metabolism and amino acid synthesis. Thus, BDQ-CUR combination therapy could potentially be applied to treat M. abscessus infections. IMPORTANCE Mycobacterium abscessus is an emerging pathogen that causes pulmonary infections, particularly in immunocompromised patients. It exhibits natural resistance to many anti-tuberculosis drugs, posing significant challenges for both patients and physicians, thereby raising the need for innovative drug discovery. Here, we describe the combined effects of bedaquiline (BDQ) and curcumin (CUR) on M. abscessus . In vitro and in vivo studies have shown that CUR enhances the inhibitory effect of BDQ. Additionally, we investigated the synergistic effects at the metabolic level. Thus, these findings highlight the potential of BDQ-CUR combination therapy against M. abscessus infections.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Shanghai Key Laboratory of Veterinary Biotechnology, School of Agriculture and Biology, Shanghai Jiao Tong University, Shanghai, Shanghai, China.
- Collaborative Innovation Center of Agri-Seeds, School of Agriculture and Biology, Shanghai Jiao Tong University, Shanghai, Shanghai, China.
Förderung
- MOST | National Key Research and Development Program of China (NKPs)
- MOST | National Natural Science Foundation of China (NSFC)
- SHANGHAI BIOMEDICAL SCIENCE AND TECHNOLOGY SUPPORT SPECIAL PROJECT
Zitieren
APA
Luo, D., Xie, W., & Wang, Z. (2025). Curcumin enhances bedaquiline’s efficacy against Mycobacterium abscessus : in vitro and in vivo evidence. Microbiology Spectrum. https://doi.org/10.1128/spectrum.02295-24
Vancouver
Luo D, Xie W, Wang Z. Curcumin enhances bedaquiline’s efficacy against Mycobacterium abscessus : in vitro and in vivo evidence. Microbiology Spectrum. 2025. doi:10.1128/spectrum.02295-24
BibTeX
@article{Luo2025,
author = {Luo, Dan and Xie, Weile and Wang, Zhe},
title = {Curcumin enhances bedaquiline’s efficacy against Mycobacterium abscessus : in vitro and in vivo evidence},
journal = {Microbiology Spectrum},
year = {2025},
doi = {10.1128/spectrum.02295-24}
}
EUVIMED